Hussman Strategic Advisors, Inc. Tandem Diabetes Care Inc Transaction History

Hussman Strategic Advisors, Inc.

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2019 Oct 31, 2019	SELL	$57.11 - $73.3 $571,100 - $733,000	-10,000 Closed	0 $0
Q2 2019 Jul 31, 2019	BUY	$54.41 - $71.7 $544,100 - $717,000	10,000 New	10,000 $645,000

346

70.9M

3.11M

181K

Ticker TNDM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 64,221,200
Market Cap $1.17B
Description
Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin c...

Get notified when there are updates to the investment portfolio of Hussman Strategic Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Hussman Strategic Advisors, Inc. with notifications on news.